Genes in Cancer

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home Genes Leukemias Tumors Cancer prone Deep Insight Case Reports Portal Journals Teaching

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Cytogenetic/clinical entity List

Updated : Tue Jul 1 08:54:15 2008

Symbol	Collaboration
Chromosome 1
1q rearrangements in multiple myeloma	DONE
dic(1;15)(p11;p11)	DONE
dup(1)(q12-21q31-32)/ALL	reserved
dup(1q)/childhood MDS	FOR_SALE
dup(1q)/myloid	FOR_SALE
i(1q) in NHL	FOR_SALE
rear. 1p/NHL or chronic Lympho	FOR_SALE
rear. 1q/NHL or chronic Lympho	FOR_SALE
t(1;1)(p36;q21) in Non Hodgkin Lymphoma	DONE
t(1;11)(p32;q23) (AML, ALL; AF1P and MLL; not rare)	DONE
t(1;11)(q21;q23)	DONE
t(1;11)(q23;p15)	DONE
t(1;11)(q24;p15) PRRX1/NUP98	FOR_SALE
t(1;12)(p36;p13)	DONE
t(1;12)(q21;p13) (AML, ALL; ARNT and ETV6; rare)	DONE
t(1;12)(q25;p13)	DONE
t(1;13)(q32;q14)	DONE
t(1;14)(p22;q32) in non Hodgkin's lymphoma (NHL)	DONE
t(1;14)(q21;q32) BCL9/IGH::t(1;22)(q21;q11)	DONE
t(1;14)(q21;q32) FCGR2B/IGH	DONE
t(1;14)(q21;q32) IRTA1/IGH::t(1;14)(q21;q32) MUC1/IGH	DONE
t(1;14)(q23;q32) (ALL, NHL, CLD; ---; rare)	DONE
t(1;14)(q23;q32)/NHL or chronic Lympho	FOR_SALE
t(1;14)(q25;q32)	DONE
t(1;16)(p31-32;q22)/ANLL	FOR_SALE
t(1;16)(q11;q11)	DONE
t(1;16)(q12;q24)	DONE
t(1;18)(q10;q10)	DONE
t(1;18)(q25;q23)	DONE
t(1;19)(p13;p13.1)	DONE
t(1;19)(q23;p13)	DONE
t(1;2)(q12;q37)	DONE
t(1;2)(q25;p23)	DONE
t(1;21)(p32;q22)	DONE
t(1;21)(p35;q22)	DONE
t(1;21)(p36;q22)	DONE
t(1;21)(q21;q22)	DONE
t(1;22) (q22;q11)/NHL ou t(1;14) (q22;q32)	reserved
t(1;22)(p13;q13)	DONE
t(1;3)(p32;p21)	DONE
t(1;3)(p36;p21)	DONE
t(1;3)(p36;q21)	DONE
t(1;5)(p32;q31)	DONE
t(1;5)(q21;q33) (MPD; TPM3/PDGFRB; rare)	DONE
t(1;5)(q22;q33)	DONE
t(1;6)(p35;p25)	DONE
t(1;7)(p32;q34)::t(1;14)(p32;q11)::1p32 rearrangements	DONE
t(1;7)(p34;q34)	DONE
t(1;7)(p36;q34)	DONE
t(1;7)(q10;p10)	DONE
t(1;7)(q21;q22)	DONE
t(1;8)(p22-p32;q22-q23)	DONE
t(1;9)(q24;q34)	DONE
Chromosome 2
Trisomy 2	DONE
inv(2)(p23q35)	DONE
rear. 2p in NHL	FOR_SALE
t(2;11)(p21;q23)	DONE
t(2;11)(q11;q23)	DONE
t(2;11)(q31;p15) (MDS, AML; NUP98 and HOXD11; rare)	DONE
t(2;11)(q31;p15) (MDS, AML; NUP98 and HOXD13; rare)	DONE
t(2;11)(q31;p15) (NUP98/HOXD11)	FOR_SALE
t(2;11)(q31;p15)/t-ANLL: (NUP98/HOXD13)	FOR_SALE
t(2;11)(q37;q23) (AML; SEPT2 and MLL; rare)	DONE
t(2;11)(q37;q23) in AML	DONE
t(2;12)(q31;p13)	DONE
t(2;13)(p16;q12)	DONE
t(2;14)(p13;q32)	DONE
t(2;17)(p23;q23)	DONE
t(2;17)(p23;q25)	DONE
t(2;19)(p11;p13)	DONE
t(2;2)(p23;q13) ALK/RANBP2	FOR_SALE
t(2;21)(p11;q22)	DONE
t(2;22)(p13;q11) (NHL; REL and IgL; rare)	DONE
t(2;22)(p13;q11) lymphoma REL/IgL	FOR_SALE
t(2;22)(p23;q11.2)	DONE
t(2;3)(p15-23;q26-27)	DONE
t(2;3)(p23;q21)	DONE
t(2;3)(q23;q26)	FOR_SALE
t(2;4)(p23;q25-q35)	DONE
t(2;5)(p23;q35)	DONE
t(2;8)(p23;p11) in t-MDS --> MYST3 / ?	FOR_SALE
t(2;9)(p11;p13)	DONE
Chromosome 3
+3 or trisomy 3 in non Hodgkin's lymphoma (NHL)	DONE
3q rearrangements in myeloid malignancies	DONE
3q21q26 rearrangements in treatment related leukemia	DONE
3q27 rearrangements in non Hodgkin lymphoma::t(3;Var)(q27;Var) in non Hodgkin lymphoma	DONE
del(3)(p14p21)	FOR_SALE
i(3q) in NHL	FOR_SALE
inv(3)(p12q26)	DONE
inv(3)(q21q26)::t(3;3)(q21;q26)::ins(3;3)(q26;q21q26)	DONE
inv(3)(q23q26)	DONE
rear. 3q/NHL or chronic Lympho	FOR_SALE
t(3;11)(p21;q23)	DONE
t(3;11)(p24;p15) (AML; NUP98 and TOP2B; rare)	DONE
t(3;11)(p24;p15) / AML	FOR_SALE
t(3;11)(q21;q23) (AML; EEFSEC and MLL; rare)	DONE
t(3;11)(q21;q23) EEFSEC/MLL	FOR_SALE
t(3;11)(q25;q23)	DONE
t(3;11)(q26;p15)	DONE
t(3;11)(q27;q23) (NHL; BCL6 and OBF1, rare)	DONE
t(3;11)(q27;q23): (BCL6/BOB1)	FOR_SALE
t(3;11)(q28;q23)	DONE
t(3;12)(q26;p13)	DONE
t(3;12)(q26;q21)	DONE
t(3;12)(q27;p13) (NHL; BCL6 and GAPD; rare)	DONE
t(3;12)(q27;q12) (NHL; BCL6 and LRMP; rare)	DONE
t(3;12)(q27;q23) (NHL; BCL6 and NACA; rare)	DONE
t(3;13)(q26;q14)	FOR_SALE
t(3;13)(q27;q14)	DONE
t(3;14)(p14;q32)	DONE
t(3;14)(q21;q32)	DONE
t(3;14)(q27;q32) (NHL; BCL6 and HSP90AA1; rare)	DONE
t(3;14)(q27;q32) BCL6/HSPCA	FOR_SALE
t(3;14)(q27;q32)::t(2;3)(p12;q27)::t(3;22)(q27;q11)	DONE
t(3;15)(q27;q22): (BCL6/)	FOR_SALE
t(3;16)(q21;q22) (AML; -- and CBFB?; rare)	DONE
t(3;16)(q21;q22)/ANLL	FOR_SALE
t(3;16)(q27;p11)	DONE
t(3;16)(q27;p13)	DONE
t(3;17)(p25;q21) (AML; -- and RARA; rare)	DONE
t(3;17)(q26;q22)	DONE
t(3;17)(q27;q11): (BCL6/)	FOR_SALE
t(3;18)(q26;q11)	DONE
t(3;18)(q27;p11) (NHL; BCL6 and EIF4A2; rare)	DONE
t(3;18)(q27;p11.2): (BCL6/EIF4A2)	FOR_SALE
t(3;19)(q27;q13) (NHL; BCL6 and NAPA; rare)	DONE
t(3;21)(q26;q22)	DONE
t(3;21)(q26;q22) in treatment related leukemia	DONE
t(3;3)(p24;q26)	DONE
t(3;3)(q25;q27) (NHL; BCL6 and MBNL1; rare)	DONE
t(3;3)(q27;q29) (NHL; BCL6 and TFRC; rare)	DONE
t(3;3)(q27;q29): (BCL6/TFRC)	FOR_SALE
t(3;4)(p21;q34)	DONE
t(3;4)(q27;p13)	DONE
t(3;5)(q21-22;q34)/myeloid	FOR_SALE
t(3;5)(q21;q31)/ANLL (AML; ---; not rare)	DONE
t(3;5)(q21;q31)/myeloid	FOR_SALE
t(3;5)(q25;q34)	DONE
t(3;5)(q26;q34)	DONE
t(3;6)(q12;q24)	reserved
t(3;6)(q25;q26)	DONE
t(3;6)(q27;p21) (NHL; BCL6 and PIM1; rare)	DONE
t(3;6)(q27;p21) (NHL; BCL6 and SFRS3; rare)	DONE
t(3;6)(q27;p21.2)(BCL6/PIM1)	FOR_SALE
t(3;6)(q27;p22): (BCL6/histone H4)	FOR_SALE
t(3;6)(q27;q15) (NHL; BCL6 and SNHG5; rare)	DONE
t(3;7)(q26;q21)	DONE
t(3;7)(q26;q34) EVI1/TCRB	FOR_SALE
t(3;7)(q27;p12-13)	DONE
t(3;8)(q21;q24)	FOR_SALE
t(3;8)(q21;q24) (AML;---; rare)	DONE
t(3;8)(q26;q24)	DONE
t(3;8)(q27;q24)	DONE
t(3;9)(p13;p13) (ALL; FOXP1 and PAX5; rare):	DONE
t(3;9)(q26;p23)	DONE
Chromosome 4
+4 or trisomy 4	DONE
4q25-28 rearr in Hodgkin disease	FOR_SALE
del(4)(q12q12) (MPD; PDGFRa and FIP1L1; not rare)::t(4;4)q12;q12) (MPD; PDGFRa and FIP1L1; not rare)	DONE
ins(9;4)(q33;q12q25) (MPD; PDGFRa and CDK5RAP2; rare)	DONE
ins(9;4)(q33;q12q25) / CEL	FOR_SALE
t(4;10)(q12;p11)	DONE
t(4;10)(q12;p11) / hypereosinophilia	FOR_SALE
t(4;11)(p12;q23)	DONE
t(4;11)(p12;q23) (B-ALL; FRYL and MLL; rare)	DONE
t(4;11)(q12;q23) MIFL/MLL	FOR_SALE
t(4;11)(q21;p15)	DONE
t(4;11)(q21;q23)	DONE
t(4;11)(q21;q23) (SEPT11/MLL)	FOR_SALE
t(4;11)(q35;q23) (AML; ArgBP2 and MLL; rare)	DONE
t(4;11)(q35;q23) (ArgBP2/MLL)	FOR_SALE
t(4;12)(p16;p13)	DONE
t(4;12)(q11-q21;p13)	DONE
t(4;14)(p16;q32)	DONE
t(4;16)(q26;p13)	DONE
t(4;17)(p11;p11)/B CLL	reserved
t(4;17)(q12;q21)	DONE
t(4;21)(q31;q22)	DONE
t(4;22)(q12;q11.2)	DONE
t(4;5)(q31;q31)	DONE
Chromosome 5
Trisomy 5	DONE
del(5q) in myeloid malignancies	DONE
dic(5;17)(q11;p11) (MDS, ANLL; -; not rare)	DONE
dic(5;17)/MDS	reserved
i(5)(p10) in acute myeloid leukemia	DONE
ins(5;11)(q31;q13q23)	DONE
t(5;10)(q33;q21)	DONE
t(5;11)(q31;q23)	DONE
t(5;11)(q35;p15.5)	DONE
t(5;12)(q31-33;p12) / B-ALL	FOR_SALE
t(5;12)(q31;p13) in MDS, AML and AEL	DONE
t(5;12)(q33;p13)	DONE
t(5;14)(q31;q32)	DONE
t(5;14)(q33;q24)	DONE
t(5;14)(q33;q32) PDGFRB/KIAA1509	DONE
t(5;14)(q33;q32) PDGFRB/TRIP11	DONE
t(5;14)(q34;q11)/ALL	FOR_SALE
t(5;14)(q35;q11)	FOR_SALE
t(5;14)(q35;q11) (CLL ; NKX2-5 and TRD; rare)	DONE
t(5;14)(q35;q11) (T-ALL; RanBP17or HOX11L2/TCR; rare)	DONE
t(5;14)(q35;q32)	DONE
t(5;14)(q35;q32) (T-ALL; TLX3 or NKX2-5 and BCL11B; rare)	DONE
t(5;14)(q35;q32.2)	DONE
t(5;15)(p15;q11-13)	DONE
t(5;15)(q33;q22)	DONE
t(5;16)(q33;q22) (AML; - ; rare)	DONE
t(5;16)(q33;q22)/ANLL	FOR_SALE
t(5;17)(q13;q21)	DONE
t(5;17)(q33;p11.2)	DONE
t(5;17)(q33;p13) (MDS; PDGFRb and RABEP1; rare)	DONE
t(5;17)(q35;q21)	DONE
t(5;21)(q13;q22)	DONE
t(5;7)(q33;q11)	DONE
t(5;9)(q33;q22)	DONE
tri 5/NHL or chronic Lympho	FOR_SALE
Chromosome 6
+6 or trisomy 6	DONE
del(6)(p21)	FOR_SALE
del(6q)	FOR_SALE
del(6q) abnormalities in lymphoid malignancies	DONE
del(6q) in Multiple Myeloma	DONE
del(6q)/ALL	FOR_SALE
del(6q)/NHL or chronic Lympho	FOR_SALE
i(6p)/ALL	FOR_SALE
i(6p)/NHL	FOR_SALE
rear. 6p/NHL or chronic Lympho	FOR_SALE
rear. 6q in NHL	FOR_SALE
t(6;11)(q13;q23)	DONE
t(6;11)(q21;q23) (AML, T-NHL; AF6q21 and MLL; rare)	DONE
t(6;11)(q21;q23)/myeloid: (AF6q21/MLL)	FOR_SALE
t(6;11)(q24;p15) C6orf80/NUP98	FOR_SALE
t(6;11)(q27;q23)	DONE
t(6;12)(p21;p13) in lymphoid malignancies	DONE
t(6;12)(q15;p13)/NHL (AML, T-CLD; - ; rare)	DONE
t(6;12)(q15;p13)/NHL or chronic Lympho	FOR_SALE
t(6;12)(q21-22;p13) (AML, B-ALL, T-ALL, CLD; FRK and ETV6 in AML; rare)	DONE
t(6;12)(q22-23;p13) (Cell line (B-ALL); STL and ETV6; rare)	DONE
t(6;12)(q23;p13) STL/ETV6	FOR_SALE
t(6;14)(p21;q32)	DONE
t(6;14)(p22;q32)	DONE
t(6;14)(p25;q32) ( CLD; IRF4 and IgH; rare)	DONE
t(6;21)(p22;q22)	DONE
t(6;7)(q23;q34)	DONE
t(6;8)(q11;q11)	DONE
t(6;8)(q27;p12)	DONE
t(6;9)(p23;q34)	DONE
Chromosome 7
-7/del(7q) in adults	DONE
-7/del(7q) in childhood	DONE
-7/del(7q)/lymphoid	reserved
del(7q) in non-Hodgkin's lymphoma (NHL)	DONE
dic(7;9)(p11-13;p11)	DONE
i(7p) in NHL	FOR_SALE
i(7q)/ALL	FOR_SALE
inv(7)(p15q34)::t(7;7)(p15;q34)	DONE
rear. 7q/NHL or chronic Lympho	FOR_SALE
t(7;11)(p14;p15) HOXA11/NUP98	FOR_SALE
t(7;11)(p14;p15) HOXA13/NUP98	FOR_SALE
t(7;11)(p15;p15)	DONE
t(7;12)(p12;q13)	DONE
t(7;12)(q32;p13)	FOR_SALE
t(7;12)(q34;p13)::t(12;14)(p13;q11)	DONE
t(7;12)(q36;p13)	DONE
t(7;14)(p15;q11)	DONE
t(7;14)(p15;q32) (AML, T-ALL; - ; rare)	DONE
t(7;14)(p15;q32)/ALL	FOR_SALE
t(7;14)(q21;q13)	DONE
t(7;14)(q21;q32) (CLD; CDK6/IgH ; rare)	DONE
t(7;14)(q21;q32) (CLD; ERVWE1/IgH ; rare)	DONE
t(7;14)(q21;q32) ERVW1/IgH	FOR_SALE
t(7;14)(q21;q32)/CLL CDK6/IgH	FOR_SALE
t(7;14)(q22;q11)	DONE
t(7;14)(q35;q32)/NHL or chronic Lympho: (TCRB/TCL1)	FOR_SALE
t(7;14)(q35;q32.1)::inv(14)(q11q32.1)::t(14;14)(q11;q32.1)	DONE
t(7;17)(p15;q23)	DONE
t(7;17)(q32-34;q23)	DONE
t(7;19)(q34;p13)	DONE
t(7;21)(p22;q22)	DONE
t(7;21)(p22;q22) USP42/AML1	FOR_SALE
t(7;22)(q34;q13)	FOR_SALE
t(7;8)(q34;p11)	DONE
t(7;9)(q11;p13)	DONE
t(7;9)(q34;q32)	DONE
t(7;9)(q34;q34)	DONE
tri 7/NHL or chronic Lympho	FOR_SALE
Chromosome 8
+8 or trisomy 8	DONE
i(8)(q10)	FOR_SALE
i(8)(q10) in acute myeloid leukaemia	DONE
inv(8)(p11q13)	DONE
t(8,14)(p11;q11)	FOR_SALE
t(8;11)(p11;p15)	DONE
t(8;12)(p12;p11)::ins(12;8)(p11;p12p22)	DONE
t(8;12)(p12;q15) (FGFR1/)	FOR_SALE
t(8;12)(q12;p13)	DONE
t(8;12)(q22;q13)	DONE
t(8;12)(q24;q22)	DONE
t(8;13)(p12;q12)	DONE
t(8;14) (q24;q11)	DONE
t(8;14)(q11;q32)	DONE
t(8;14)(q24;q32)::t(2;8)(p12;q24)::t(8;22)(q24;q11)	DONE
t(8;16)(p11;p13)	DONE
t(8;16)(p11;p13) in treatment related leukemia	DONE
t(8;17)(p12;q23)	DONE
t(8;17)(p12;q25) (FGFR1/)	FOR_SALE
t(8;17)(q13;q23)	FOR_SALE
t(8;17)(q13;q23) (CML; -; rare)	DONE
t(8;19) (p11;q13)	DONE
t(8;19)(p12;q13)	DONE
t(8;21)(q22;q22)	DONE
t(8;21)(q22;q22) in treatment related leukemia	DONE
t(8;21)(q24;q22)	DONE
t(8;22) (p11;q13)	DONE
t(8;22)(p11;q11)	DONE
t(8;9)(p12;q33)	DONE
t(8;9)(p22;p24)	DONE
tri 8 in ANLL	FOR_SALE
Chromosome 9
+9 or trisomy 9	DONE
9p Rearrangements in ALL	DONE
9p rearr/NHL	FOR_SALE
I(9q) in ALL	DONE
amplified NUP214/ABL1	DONE
del(9p)/ALL	FOR_SALE
del(9q) solely	DONE
der(9;18)(p10;q10)	DONE
dic(9;12)(p13;p13)	DONE
dic(9;20)(p11-13;q11)	DONE
monosomy 9 /ALL	FOR_SALE
rear. 9q/NHL or chronic Lympho	FOR_SALE
t(9;11)(p22;p15)	DONE
t(9;11)(p22;q23)	DONE
t(9;11)(q34;p15)	DONE
t(9;11)(q34;q23) (AF9q34-MLL)	DONE
t(9;11)(q34;q23) FBP17/MLL	DONE
t(9;12)(p24;p13)	DONE
t(9;12)(q13;p13)/ (PAX5/ETV6)	FOR_SALE
t(9;12)(q22;p12)	DONE
t(9;12)(q34;p13)	DONE
t(9;14)(p13;q32)	DONE
t(9;14)(q34;q32)	DONE
t(9;17)(q34;q23) ( NHL; - ; rare)	DONE
t(9;17)(q34;q23)/NHL or chronic Lympho	FOR_SALE
t(9;21)(p22;q22)	DONE
t(9;21)(q13;q22)	FOR_SALE
t(9;21)(q34;q22)	DONE
t(9;22)(p24;q11.2)	DONE
t(9;22)(q34;q11) in ALL	DONE
t(9;22)(q34;q11) in ANLL	DONE
t(9;22)(q34;q11) in CML	DONE
t(9;22)(q34;q11) in treatment related leukemia	DONE
t(9;9)(q34;q34)	DONE
Chromosome 10
+10 or trisomy 10 (solely)	DONE
del(10q)/NHL	FOR_SALE
t(10;11)(p11.2;q23)	DONE
t(10;11)(p12;q23)	DONE
t(10;11)(p13;q21)	DONE
t(10;11)(q22;q23)	DONE
t(10;11)(q22;q23) (MLL)	FOR_SALE
t(10;11)(q25;p15)	DONE
t(10;12)(q24;p13)	FOR_SALE
t(10;12)(q24;p13) / MDS	FOR_SALE
t(10;14)(q24;q11)/NHL (T-ALL; NFKB2 and TCRA-D, not rare)	DONE
t(10;14)(q24;q11)::t(7;10)(q34;q24)	DONE
t(10;14)(q24;q32) (B-NHL; NFKB2 and IGH; rare)	DONE
t(10;14)(q24;q32)/NHL or chronic Lympho: (LYT10/IgH)	FOR_SALE
t(10;16)(q22;p13)	DONE
t(10;21)(p12;q22)	FOR_SALE
Chromosome 11
+11 or trisomy 11 (solely)	DONE
11p15 rearrangements in treatment related leukemia	DONE
11q22-23 rearr in NHL	FOR_SALE
11q23 rearrangements in childhood acute lymphoblastic leukemia	DONE
11q23 rearrangements in leukaemia	DONE
11q23 rearrangements in therapy related leukaemias	DONE
del(11)(p12p13)	DONE
del(11q) in non-Hodgkin's lymphoma (NHL)	DONE
del(11q)/MDS	FOR_SALE
del(11q)/MLL	FOR_SALE
inv (11)(p15q23)/ANLL-MDS (MLL)	FOR_SALE
inv(11)(p15q22)::t(11;11)(p15;q22)	DONE
inv(11)(q21;q23) in therapy related leukemias	DONE
t(11;11)(q13;q23) (MLL)	FOR_SALE
t(11;11)(q14;q23) (PICALM/MLL)	FOR_SALE
t(11;11)(q23;q23) (ARHGEF12/MLL)	FOR_SALE
t(11;11)(q23;q23) (CBL/MLL)	FOR_SALE
t(11;11)(q24;q23) (TIRAP/MLL)	FOR_SALE
t(11;12)(p15;p13)	DONE
t(11;12)(p15;q13)	DONE
t(11;12)(p15;q13) NUP98/HOXC13	FOR_SALE
t(11;12)(q23;q13) (/HMGA2)	DONE
t(11;12)(q23;q13) (MLL)	FOR_SALE
t(11;12)(q23;q13) (MLL/CIP29)	DONE
t(11;13)(q23;q14)	FOR_SALE
t(11;14)(p11;q32)	DONE
t(11;14)(p13;q11)::t(7;11)(q35;p13)	DONE
t(11;14)(p13;q13)/ALL	FOR_SALE
t(11;14)(p15;q11)	DONE
t(11;14)(q13;q32)	DONE
t(11;14)(q13;q32) in multiple myeloma	DONE
t(11;14)(q23;q24)	DONE
t(11;14)(q23;q32) DDX6/IgH	FOR_SALE
t(11;14)(q23;q32) PAFAH1B2/IgH	FOR_SALE
t(11;14)(q23;q32) PCSK7/IgH	FOR_SALE
t(11;15)(q23;q14)	DONE
t(11;15)(q23;q14) (MLL/MPFYVE)	FOR_SALE
t(11;15)(q23;q15): (MLL/...	reserved
t(11;17)(p15.5;q21)	FOR_SALE
t(11;17)(q13;q21)	DONE
t(11;17)(q23;p13)	DONE
t(11;17)(q23;q12) MLL/RARa	DONE
t(11;17)(q23;q12-21) MLL/AF17	DONE
t(11;17)(q23;q12-21) MLL/LASP1	DONE
t(11;17)(q23;q21)	DONE
t(11;17)(q23;q21) (MLL/ACACA)	FOR_SALE
t(11;17)(q23;q23)	FOR_SALE
t(11;17)(q23;q25)	DONE
t(11;18)(q21;q21)	DONE
t(11;18)(q23;q23) (MLL)	FOR_SALE
t(11;19)(q23;p13) (MLL/MYOF1)	FOR_SALE
t(11;19)(q23;p13)/ANLL (MLL/EEN)	FOR_SALE
t(11;19)(q23;p13.1)	DONE
t(11;19)(q23;p13.3)	DONE
t(11;20)(p15;q11)	DONE
t(11;20)(q23;q11)	DONE
t(11;21)(p13;q22) ?/AML1	FOR_SALE
t(11;21)(q23;q11) (MLL)	FOR_SALE
t(11;22)(q23;q11.2)	DONE
t(11;22)(q23;q13)	DONE
tri 11/NHL or chronic Lympho	FOR_SALE
Chromosome 12
+12 or trisomy 12	DONE
12p abnormalities in myeloid malignancies	DONE
12p rearrangements in ALL	DONE
12p rearrangements in CLL	DONE
12p13 rearrangements in treatment related leukemia	DONE
t(12;12)(p13;q13)	FOR_SALE
t(12;12)(p13;q13) / B-ALL	FOR_SALE
t(12;13)(p11;q14)	FOR_SALE
t(12;13)(p12;q12-14)	DONE
t(12;13)(p13;q12)	FOR_SALE
t(12;13)(p13;q12) (MPD; ETV6 and FLT3; rare)	DONE
t(12;13)(p13;q14)	FOR_SALE
t(12;13)(p13;q14) (B-ALL; ETV6 and TTL; rare)	DONE
t(12;13)(p13;q14)/ALL	FOR_SALE
t(12;13)(p13;q22)	FOR_SALE
t(12;14)(p13;q11)/T-ALL	FOR_SALE
t(12;14)(p13;q32)	DONE
t(12;14)(q13;q31)	DONE
t(12;15)(p12-13;q13-15)	FOR_SALE
t(12;15)(p13;q25)	DONE
t(12;17)(p11;q11) in AML	DONE
t(12;17)(p12;q11) ALL ZNF384/TAF15	FOR_SALE
t(12;17)(p13;p12) ETV6/PER1	FOR_SALE
t(12;17)(p13;q11-21) in ALL	DONE
t(12;19)(p12;p13) / ALL ZNF384/E2A	FOR_SALE
t(12;20)(q15;q11.2).	DONE
t(12;21)(p12;q22)	DONE
t(12;21)(q12;q22)	DONE
t(12;21)(q24;q22)	DONE
t(12;22)(p12;q12) AL ZNF384/EWSR1	FOR_SALE
t(12;22)(p13;q11) (AML; MN1 and ETV6; rare)	DONE
t(12;22)(p13;q11) (NHL; CCND2 and IgL; rare)	DONE
t(12;22)(p13;q11)/ lineage CCND2/IgL	FOR_SALE
t(12;22)(p13;q11-12)	DONE
t(14;22)(q32;q11) (MPD, AML, ALL, T-NHL, CLD; -; not rare)	DONE
Chromosome 13
+13,+13 or tetrasomy 13	DONE
del (13q)	DONE
del (13q) in chronic lymphoproliferative diseases	DONE
del(13q) in ALL	DONE
del(13q) in multiple myeloma	DONE
del(13q) in myeloid malignancies	DONE
del(13q) in non-Hodgkin's lymphoma	DONE
del(13q)/B-CLL	reserved
del(13q)/T-NHL	FOR_SALE
rear. 13q/NHL or chronic Lympho	FOR_SALE
tri 13/myeloid	FOR_SALE
Chromosome 14
+14 or trisomy 14 (solely)	DONE
del(14q)/NHL or chronic Lympho	FOR_SALE
inv(14)(q11q32) TCRA-D/IgH	FOR_SALE
rear. 14q11/NHL or chronic Lympho: (TCR/)	FOR_SALE
rear. 14q11/T-ALL	FOR_SALE
rear. 14q32/NHL or chronic Lympho: (IgH/)	FOR_SALE
t(14 ;21)(q11;q22)	DONE
t(14;14)(q11;q32) (B-ALL; CEBPE and IgH; rare)	DONE
t(14;14)(q11;q32) CEBPE/IgH	FOR_SALE
t(14;15)(q32;q12) IgH/MALT1	FOR_SALE
t(14;18)(q32;q21) (IgH/BCL2)::t(2;18)(p11;q21)::t(18;22)(q21;q11)	DONE
t(14;18)(q32;q21)(IgH/MALT1)	DONE
t(14;19)(q32;q13)	DONE
t(14;19)(q32;q13) in acute lymphoblastic leukaemia	DONE
t(14;20)(q32;q11) in multiple myeloma	FOR_SALE
t(14;20)(q32;q13) CEBPB/IgH	FOR_SALE
t(14;21)(q22;q22)	DONE
t(14;22)(q32;q11)/ALL	FOR_SALE
Chromosome 15
+15 or trisomy 15 (as sole autosomal abnormality)	DONE
15q13-15 Rearrangements	DONE
t(15;17)(q22;q21)	DONE
t(15;17)(q22;q21) in treatment related leukemia	DONE
t(15;21)(q22;q22)	DONE
Chromosome 16
inv(16)(p13q22) in treatment related leukemia	DONE
inv(16)(p13q22)::t(16;16)(p13;q22)::del(16)(q22)	DONE
t(16;21)(p11;q22)	DONE
t(16;21)(q24;q22)	DONE
Chromosome 17
del(17p) in myelo�d malignancies	DONE
del(17p) in non-Hodgkin's lymphoma (NHL)	DONE
i(17q) in myeloid malignancies	DONE
i(17q)/ALL	FOR_SALE
i(17q)/NHL	FOR_SALE
t(17;17)(q11;q12) /APL	FOR_SALE
t(17;19)(q22;p13)	DONE
t(17;21)(q11.2;q22)	DONE
tri 17	reserved
Chromosome 18
+18 or trisomy 18 in lymphoproliferative disorders	DONE
del(18)(p11)	FOR_SALE
mono 18	FOR_SALE
t(18;21)(q21;q22)	DONE
Chromosome 19
Trisomy 19	DONE
inv(19)(p13q13)	FOR_SALE
t(19;21)(q13.4;q22)	DONE
Chromosome 20
del(20q) in myeloid malignancies	DONE
ider(20q) in Myeloid Malignancies	DONE
t(20;21)(q11;q22)	DONE
t(20;21)(q13;q22)	DONE
Chromosome 21
+21 or trisomy 21	DONE
-21 or monosomy 21 (solely)	DONE
21q22 rearr	FOR_SALE
21q22 rearrangements in treatment related leukemia	DONE
dup(21q) amplified (RUNX1)	DONE
i(21q)	FOR_SALE
t(21;21)(q11;q22): USP25/AML1	FOR_SALE
Chromosome 22
+22 or trisomy 22 (solely?)	DONE
Chromosome X
idic(X)(q13)	DONE
t(X;10)(p10;p10)	DONE
t(X;11)(q13;q23)	DONE
t(X;11)(q21;q23)	DONE
t(X;11)(q24;q23) (AML; SEPT6 and MLL; rare)	DONE
t(X;14)(q28;q11) (CLD; MTCP1 and TRA-D; rare)	DONE
t(X;2)(q11;p23)	DONE
t(X;20)(q13;q13.3)	DONE
t(X;21)(p22;q22)	DONE
t(X;21)(q26;q22) (AML; ELF4 and ERG; rare)	DONE
Chromosome NA
-X	FOR_SALE
-X/+X/-Y in NHL or CLD	FOR_SALE
8p11 myeloproliferative syndrome	FOR_SALE
ALL with hypereosinophilia	FOR_SALE
Abnormal chromatin clumping syndrome	FOR_SALE
Acute Erythroid leukaemias	DONE
Acute basophilic leukemia::t(X;6)(p11;q23)	DONE
Acute megakaryoblastic leukemia (AMegL)::M7 acute non lymphocytic leukemia (M7-ANLL)	DONE
Acute myelofibrosis (M7 with prominent fibrosis)	FOR_SALE
Adult T-cell leukemia/lymphoma (ATLL)	DONE
Anaplasic large cell lymphoma (ALCL)	DONE
Angio immonoblastic lymphadenopathy (T-NHL)	reserved
Angioimmunoblastic T-cell lymphoma	DONE
Atypical Chronic Myeloid Leukemia (aCML)	DONE
B-cell anaplastic lymphoma	FOR_SALE
B-cell prolymphocytic leukemia (B-PLL)	DONE
Biphenotypic Acute Leukaemia (BAL)	DONE
Burkitt's lymphoma (BL)	DONE
Castleman's disease	DONE
Childhood T-cell ALL	reserved
Childhood myelodysplastic syndromes	DONE
Chronic Myelomonocytic Leukemia (CMML)	DONE
Chronic eosinophilic leukemia/idiopathic hypereosinophilic syndrome	FOR_SALE
Chronic lymphocytic leukaemia (CLL)	DONE
Chronic myelogenous leukaemia (CML)	DONE
Classification of B-cell chronic lymphoproliferative disorders (CLD)	DONE
Classification of B-cell non-Hodgkin lymphomas (NHL)	DONE
Classification of T-Cell disorders	DONE
Classification of acute myeloid leukemias	DONE
Classification of myelodysplasic syndromes	DONE
Cutaneous T-cell lymphomas	DONE
Diffuse large cell lymphoma	DONE
Essential Thrombocythemia (ET)	DONE
Fibrogenesis imperfecta ossium	DONE
Follicular lymphoma (FL)	DONE
Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia Variant (HCL-V)	DONE
Hepatosplenic lymphoma	FOR_SALE
High hyperdiploid acute lymphoblastic leukaemia	DONE
Histiocyte-rich B-cell lymphoma	FOR_SALE
Hodgkin's disease	DONE
Infant leukaemias::Congenital leukaemias::Neonatal leukaemias	DONE
Intestinal T-cell lymphoma	FOR_SALE
Juvenile Chronic Myelogenous Leukemia (JCML)	DONE
Lymphoepithelioid lymphoma	DONE
Lymphoplasmacytic lymphoma	DONE
M0 acute non lymphocytic leukemia (M0-ANLL)	DONE
M3/M3v acute non lymphocytic leukemia (M3-ANLL)::M3/M3v acute myeloid leukemia (AML M3/M3v)::Acute promyelocytic leukemia (APL)	DONE
Mantle cell lymphoma (incomplete)	DONE
Marginal Zone B-cell lymphoma	DONE
Mucosa-associated lymphoid tissue (MALT) lymphoma	DONE
Multiple myeloma	DONE
Mycosis fungoides/Sezary's syndrome	DONE
Myelofibrosis with Myeloid Metaplasia (MMM)::Idiopathic myelofibrosis::Agnogenic myeloid metaplasia	DONE
Myeloid metaplasia post PV	reserved
Myeloproliferative/Myelodysplastic syndromes	FOR_SALE
NK cell neoplasias	DONE
Nasal T cell lymphoma	DONE
Near haploid acute lymphoblastic leukaemia	DONE
Plasma cell leukemia (PCL)	DONE
Polyclonal B Lymphocytosis with Binucleated Lymphocytes (PPBL)	DONE
Polycythemia Vera (PV)	DONE
Primary cutaneous CD30+ anaplastic large cell lymphoma	DONE
RAEB I	FOR_SALE
RAEB II	FOR_SALE
Refractory anemia (RA)	DONE
Refractory anemia with excess blasts (RAEB)	DONE
Refractory anemia with ringed sideroblasts (RARS)	DONE
Refractory cytopenia with minimal dysplasia (RC)	FOR_SALE
Refractory cytopenia with multilineage dysplasia (mRC)	FOR_SALE
Severe hypodiploid acute lymphoblastic leukaemia	DONE
Sezary	reserved
Small lymphocytic lymphoma	DONE
Splenic lymphoma with villous lymphocytes (SLVL)	DONE
Systemic mast cell disease (SMCD)	DONE
T-cell large granular lymphocyte leukaemia	DONE
T-cell prolymphocytic leukemia (T-PLL)	DONE
T-lineage acute lymphoblastic leukemia (T-ALL)	DONE
T-lymphoblastic Lymphoma/leukaemia	FOR_SALE
T-lymphoblastic lymphoma/leukemia (T-Lbly/T-ALL)	FOR_SALE
Treatment related leukemias	FOR_SALE
Waldenstrom's macroglobulinemia (WM)	DONE
body cavity based lymphoma	FOR_SALE
centroblastic lymphoma	FOR_SALE
hyperploidy � 50	reserved
immunoblastic lymphoma	FOR_SALE
leukaemias in Down Syndrome	FOR_SALE
lymphomatoid papulosis (benign)	FOR_SALE

Please contact
Jean-Loup Huret, Genetics University Hospital
F-86021 POITIERS FRANCE
email : j.l.huret@chu-poitiers.fr.
tel +33 5 49 44 45 46
fax +33 5 49 44 41 31 (or... 39 80)

Home Genes Leukemias Tumors Cancer prone Deep Insight Case Reports Portal Journals Teaching

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA